Back

Clinical effectiveness of primary prevention implantable defibrillators: results of the EU-CERT-ICD non-randomised, controlled, multicentre study

2 September 2019 (09:24 - 09:42)
Organised by:
Congress Presentation Part of: Late Breaking Science in Heart Failure 1 Implantable Cardioverter-Defibrillator (ICD) ESC Premium Access ESC Congress 2019

About the speaker

Photo
Associate Professor Markus Zabel

University Medical Centre of Gottingen (UMG), Goettingen (Germany)

4 More presentations in this session

Presentation thumbnail
Spironolactone in atrial fibrillation with preserved cardiac contractility
Doctor E. Shantsila (Liverpool, GB)
Slides Video
Presentation thumbnail
Effects of Sacubitril-Valsartan Compared with Enalapril on Arterial Hemodynamics and Cardiac Remodeling in Patients with Heart Failure and Reduced Ejection Fraction
Doctor A. Desai (Boston, US)
Slides Video
Presentation thumbnail
Effects of Angiotensin Receptor/Neprilysin Inhibitor Therapy on NT-proBNP and Cardiac Remodeling in Heart Failure with Reduced Ejection Fraction: Primary Results of the PROVE-HF Study
Professor J. Januzzi (Boston, US)
Slides Video
Presentation thumbnail
Clinical phenotypes, gender differences and adverse events associated with truncating variants in the Titin (TTN) gene
Doctor M. Akhtar (London, GB)
Slides Video

Access the full session

Session thumbnail
Late Breaking Science in Heart Failure 1

The Event

Event poster

ESC Congress 2019

2 September 2019 09:24 CET
You may be interested in
thumbnail
Congress Session
Debate on primary prevention in ICD therapy
thumbnail
Congress Session
Implantable cardioverter defibrillator therapy
thumbnail
Congress Session
Hot topics in the management of ventricular tachycardia and sudden cardiac death

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources